4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011829
Chief Operating Officer sold 68,750 shares at an average $17.86 ($1,227,988)
- Chief Operating Officer acquired 42,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN BRUCE D Chief Operating Officer | 2019-02-15 | Sale | −26,250 | $17.67 | $463,838 | 644,606 | D |
| GIVEN BRUCE D Chief Operating Officer | 2019-02-19 | Option exercise | +42,500 | $2.01 | $85,425 | 687,106 | D |
| GIVEN BRUCE D Chief Operating Officer | 2019-02-19 | Sale | −42,500 | $17.98 | $764,150 | 644,606 | D |
| Derivatives | |||||||
| GIVEN BRUCE D Chief Operating Officer | 2019-02-19 | Option exercise · Stock Option (right to buy) | −42,500 | 435,000 | D | ||
| Open-market sales · 68,750 sh · avg $17.86 · $1,227,988 | |||||||
Loading xslF345X03/doc4.xml…